We are very pleased to announce the 7th International Fluid Academy Days, which will take place on November 23-24th 2018 at Pakhuis De Zwijger, Amsterdam.
The aim of this sixth edition is again to review recent advances in fluid management, and hemodynamic and organ function monitoring in the critical care setting in a comprehensive manner for intensivists, anaesthesiologists and emergency physicians as well as interested internists and surgeons. However the meeting will deal with any broad topic related to critical care. As always it is also a great way to promote professional interaction between faculty members, participants and delegates of the industry.
This website does not accept nor host any advertisement.
Download the information brochure here
The next generation of anaesthetic logbook
AnaestheticsApp is the next generation of logbook that links your cases to the Royal College of Anaesthetists (RCoA) curriculum, relevant journal articles and exam questions. It is the first anaesthetic logbook that specifically focuses on education and exam revision. Our forms are designed to allow fast data entry and only show procedures relevant to the chosen speciality. Logbook reports can be printed and are compliant with the Annual Review of Competence Progression (ARCP). An integrated paediatric calculator helps to reduce drug errors. Our Progressive Web App uses the newest web technologies to allow offline use on phones, tablets and laptops. The app is free to use and can be installed directly from your browser (requires Google Chrome 68, Microsoft Edge 17 or Apple Safari on iOS 11.3).
B. Braun supports the International Fluid Academy first of all because of their mutual interest in fluid management. Therefore you can find us at our booth during the 10th International Fluid Academy Days November 2020 in Brussels. Our B. Braun colleagues are more than willing to share expertise about the recent developments in fluid management!
Who is B. Braun? B. Braun is one of the world's leading providers of healthcare products today. We supply the global healthcare market with products and systems for anesthesia, intensive care, cardiology, extracorporeal blood treatment and surgery. We also provide services for clinics, physicians in private practices and the home care sector.
Created in 2001, congres-medical.com is the first platform referencing and promoting medical events. Congres-medical.com is also a directory listing of websites, sites and companies providing the event. The site offers publishing tools allowing members to announce, reference, share, broadcast content moderated and validated by the team of congres-medical.com in the field of health, (Congress, Congress exhibition venues, event service providers, medical providers,...). Under "News" has become a directory of content aggregation and distribution of information. "RSS (Really Simple Syndication)" is the new standard for exchange of content. It is performed by a professional team in partnership with info-live.com (French version). The ambition of writing congres-medical.com is to inform users and professionals independently with great attention to quality and reliability. The editorial team runs, detects, moderates, validates and distribute all the contents on social network and partner websites. For communication without borders ! Thank you for your attention and loyalty. **congres-medical.com is totally free**
Proud disseminating the great work of others
Critical Care Northampton is an online resource for all that is FOAMed / FOAMcc and of course POCUS. We have an ever expanding following with a growing team and provide weekly updates on what is big and being talked about within Critical Care. Our other aim is to provide a wealth of useful resources; to download, learn from and teach with. We also feature regular blogs on hot topics / areas of controversy welcoming guest publishers. We pride ourselves in disseminating the great work of others, whether web based or not, and continue to expand this network so others may benefit from it. The International Fluid Academy is just one of those links we are very proud to have.
As I learn you learn too
My name is Jonathan Downham and I am an Advanced Critical Care Practitioner in Warwick, UK.
I have worked in Critical Care for over 20 years now and have learned many things whilst there. This site has some of my teaching resources, podcasts and videos for anyone else to benefit from.
If you want to follow me on Twitter then look for @ccpractitioner. I am very active on there and it is the best way to get in touch with me quickly.
Biotherapies for Life
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ needs using the latest technologies to develop and deliver innovative therapies. The company offers the broadest range of products in the industry for treating coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. CSL Behring’s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn. The company operates one of the world’s largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia, employs more than 22,000 people, and delivers its life-saving therapies to people in more than 60 countries. For more information visit at CSLBehring.com/Vita and follow us on Twitter.com/CSLBehring.
CytoSorbents is a critical care immunotherapy company commercializing its CE approved CytoSorb, a safe and effective cytokine adsorber. CytoSorb is designed to attenuate the dysregulated, hyperinflammatory response („cytokine storm“) present in septic shock and other, non-infectious systemic hyperinflammatory states by reducing elevated levels of cytokines and other inflammatory mediators. This modulation of the immune response can lead to an improvement of hemodynamics, a reduction in the need for vasopressors and overall to an increased chance for recovery of organ functions and improved patient outcomes. CytoSorb is indicated in various hyperinflammatory states of infectious and non-infectious origin, e.g. after cardiac surgery, in cardiogenic shock, trauma, burns, pancreatitis and infection. So far it has been used safely and well tolerated in more than 27,000 single treatments worldwide. CytoSorb Therapy – REGAIN CONTROL!
An Open Access Journal on Fluids
Fluids (ISSN 2311-5521) is an open access journal, which provides an advanced forum for studies on fluid dynamic theory and its applications, and fluid simulation, modeling and experimentation in chemical, physical and biological processes. Our aim is to publish state-of-the-art papers, including original research papers, reviews, case reports, as well as technical notes and meeting reports. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
Fluids is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications. MDPI works with Publons to provide reviewers with credit for their work.
Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers in the U.S. market. All over the world more than 24,000 employees are committed to improving the quality of life of critically and chronically ill patients with innovative products for patients in hospitals and outpatients.
Getinge AB is a Sweden-based company active in the healthcare sector. It provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas: The Medical Systems business area offers equipment for surgical disciplines, cardiology and intensive care; the Extended Care business area offers products and services geared toward the hospital and elderly care markets, including solutions for preventing the risk of pressure ulcers and deep vein thrombosis, and the Infection Control business area features systems for preventing the occurrence and spread of infection. Its products comprise disinfectors, sterilizers, including low temperature sterilization solutions, information technology (IT) solutions, as well as advice, training and technical support. The Company's products are sold under the Getinge, Lancer, ArjoHuntleigh and MAQUET brands.
Maltron is a leading manufacturer of Bio-electrical and Electrical Impedance Tomography used in the assessments of Body and Abdominal Composition, Malnutrition, Fluid Monitoring and for monitoring lung diseases bedside by leading hospitals and institute worldwide. The company focus is on the research, development, manufacture and marketing of innovative products. Maltron products are well known for quality, reliability and consistent reproducibility providing reliable assessment of Body Composition and hydration in a simple, safe and scientific manner.
We are the largest privately owned and independent plasma fractionator in the world
Family-owned since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 countries and reach hundreds of thousands of patients every year. We focus on three therapeutic areas: haematology, immunotherapy and critical care.
Octapharma is one of the largest human protein product manufacturers. We develop and produce medicines based on human proteins from human cell lines and human plasma, sourced from our own plasma donation centres and other external sources.
Working at Octapharma
Octapharma focuses on long-term success and recognises the value of teamwork. We have a multicultural working environment filled with highly engaged people of diverse backgrounds and talents. Our five company values are: Ownership, Integrity, Leadership, Sustainability and Entrepreneurship. We aspire to embody these values in everything we do, every day.
To facilitate the rapid adoption of clinical education into clinical practice in order to improve patient outcomes.
Global physicians and healthcare professionals have been participating in our digital activities for over 15 years to acquire new clinical skills, test their knowledge, and improve their practice of medicine.
We carefully design interactive activities to challenge and address the unmet educational needs of your peers within the medical community. All activities are delivered in multiple formats, which can be consumed quickly, at any time, from any place, and on any device on a proven platform which professionals trust.
PeerVoice is a provider of independent medical education developed in concert with leading experts from around the world. Some activities are also certified for continuing medical education (CME) credits by a European accrediting body.
www.propofology.com is an UK based, international project created out of the desire to advance FOAMed (Free Open Access to Medical Education) to everyone involved in anaesthesia, critical care and pain medicine. The website focuses on delivering ‘infograms’, or small graphic tutorials on topics pertinent to these fields; aiming to distill complicated topics into short ‘bytes'. There are over one hundred infographics to peruse and learn from as well as a medical student section, opinion articles and signposts. There is also an expanding collection of YouTube videos, so be sure to subscribe to the YouTube channel to keep up to date! The content is disseminated on Twitter to the #FOAMed network and is particularly useful not only for those practicing in anaesthesia and critical care, but also individuals revising for specialty and medical school examinations.
New predictive window to Kidney Health
The Serenno system is a pioneering Urine Output (UO) Monitor for hospitalized patients improving Acute Kidney Injury (AKI) prediction and fluid management.
Social Media and Critical Care
SMACC is a FOAMed charity that promotes education and knowledge sharing in Critical Care. They also host an epic conference! SMACC (Social Media and Critical Care) is a health promotion charity. It is based on the philosophy of FOAM (Free Open Access Medical education – #FOAMed). The organising committee gives their time freely and receives no financial benefit. This in part explains the wonderful passions for philanthropy, sharing, education and innovation that make this critical care community so unique.
SMACC has seen spectacular growth since its humble beginnings. The Conference has grown from an enthusiastic idea into a global leader amongst critical care events. Whilst SMACC is primarily a high quality, academic meeting, the real reason behind this growth is the enormous and inspiring energy of the critical care community itself. SMACC crosses traditional hierarchies, professional barriers and international borders. It is a community that is centered on the pursuit of excellence in patient care and a passion for sharing this as widely as possible.
Stay tuned with the latest publications
Welcome to The Bottom Line (TBL). This site has been built to create a compendium of all the landmark papers which are shaping the way we manage our critically ill patients. Each paper has been summarised and critiqued using a standard template and ends with a 'bottom line' paragraph to allow a quick reminder of the key points. The papers are reviewed and cross checked by the editorial group. We take this seriously and spend time getting it accurate and as helpful for our readers as possible. If you think we have got it wrong, please let us know or use it as a discussion in the comments section. The main value of this site is the discussion of these papers and the contribution of the global FOAM community. We hope you enjoy!
Advancing medical practice
The Wessex Intensive Care Society (WICS) was established in the 1980's. It has rapidly developed into a society which brings together intensive care health professionals across the Wessex region.
Our aim is to advance medical practice within our intensive care units and hospitals and provide supportive training and quality education.
The Vygon Company strategy is clear, offer health professionals efficient and innovative single-use medical products adapted to their needs. With a high degree of quality and at a competitive price, we offer health-care professionals the best possible chances to treat and care for their patients in the most secured conditions.
Innovation requires an understanding: our teams of marketing, R&D and sales representatives are working daily with our customers, listening to their needs, bringing creative and imaginative solutions to patient care. This high quality and responsive service compliments the proximity of production and research. That is why our plants are still located in Europe and in the United States of America. It’s our key to ensure constant high quality products.
This policy and strategy, requires long term commitment and a real involvement of all Vygon partners and managers. Stability and commitment of our shareholders enable us to invest in the long term, opting for quality and innovation instead of short term profitability, giving our teams and clients the warranty of a long term vision that everybody needs.
This willingness to act in the long term, some talk about Sustainable Development Strategy (SDS), allows Vygon to implement its leading vision of progress, integrating all stakeholders, in social, economic and environmental outcomes.
This strategy has proven to be effective. Since fifty years now, Vygon attracts more and more partners around the world. We are now present in more than one hundred countries in five continents. Our regular growth and profitability, warranty of our independence and our ability to innovate, testifies the quality of our products and our customer satisfaction.